BATABULIN SODIUM
UNII G04B77F772

Substance Identification & Data

This profile provides standardized clinical and technical data for Batabulin Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) G04B77F772.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 195533-98-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

G04B77F772

CAS Registry Number

195533-98-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BATABULIN SODIUM

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C13H6F6NO3S.Na

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

UWPXRVDIKGZQQW-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C1835

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

23669770

Unique identification number in the NCBI database of chemical substances.

USAN ID

PP-06

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

S(c1c(c(F)c(c(c1F)F)F)F)([N-]c2cc(c(OC)cc2)F)(=O)=O.[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Batabulin Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.